Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Coastal Financial Corporation following the company's report of a $42.1 million net loss in Q2 2026, largely due to a $68.8 million credit expense linked to a single partner. This loss caused Coastal's stock to drop 43.5% in one day. The investigation seeks to determine if Coastal misled investors, with Kaplan Fox inviting affected investors to come forward. The outcome could impact shareholder recoveries and corporate accountability.
Baldwin Group is going private in a $7.7 billion all-cash deal led by Sequence Holdings and DFO Management, offering shareholders $32.50 per share, an 88% premium over the June 2026 price. The transaction will delist Baldwin from Nasdaq and is expect...
BTIG increased its price target for Cullinan Therapeutics to $40, reflecting a potential 93% upside from the current stock price of around $20.73. This upgrade follows successful Phase 3 trial results for zipalertinib, a treatment for non-small cell ...
Kroger reported mixed Q2 earnings with adjusted EPS of $1.09 beating estimates, but revenues slightly below expectations at $34.62 billion. Despite slower sales growth, Kroger maintained its full-year adjusted EPS guidance of $5.10 to $5.30, supporte...
The US 10-year Treasury yield briefly surged past 5% for the first time since 2023, driven by record-high diesel prices and concerns over inflation linked to the Middle East conflict. This rise in yields is significant as it influences mortgage rates...
Moderna and Merck announced that their AI-built cancer vaccine, intismeran autogene, achieved positive Phase 3 results in melanoma patients, marking the first success for a personalized cancer therapy. The vaccine uses AI to analyze each patient's tu...
